Zhang, F., Zhong, W., Li, H., Huang, K., Yu, M., & Liu, Y. (2021). TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer. Front Cell Dev Biol.
Citação norma ChicagoZhang, Feng, Wenhui Zhong, Honghao Li, Kaijun Huang, Min Yu, and Yubin Liu. "TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer." Front Cell Dev Biol 2021.
MLA citiranjeZhang, Feng, et al. "TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer." Front Cell Dev Biol 2021.
Opozorilo: Ti citati niso vedno 100% točni.